(GoRealNewsNow.com) – Kirkland Signature, the off-brand counterpart to well-known Nyquil and Dayquil, is recalling its Severe Cold & Flu Plus Congestion product over concerns regarding a pivotal ingredient facing potential Food Drug Administration (FDA) regulation.
The FDA’s overreach threatens a key ingredient in this over-the-counter remedy, potentially leaving consumers with fewer relief options.
Approximately 8,640 boxes of Kirkland Signature Severe Cold & Flu Plus Congestion medicine, an off-brand version of Dayquil and Nyquil, have been recalled from Costco shelves.
This recall comes amid growing concerns about the effectiveness of a key ingredient, phenylephrine, which the FDA is considering banning.
The recall is officially attributed to “CGMP deviations,” which are quality control issues. However, this comes suspiciously close to the FDA’s recent scrutiny of oral phenylephrine, a common decongestant in many cold and flu medicines.
An outside panel of experts has already voted against the efficacy of orally administered phenylephrine, paving the way for potential government overreach in regulating over-the-counter medications.
The FDA has classified this as a Class II recall, indicating that “use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
Meanwhile, consumers who have purchased the affected product are being advised to either dispose of it or return it to Costco.
The recalled medicine includes a 168-count twin pack with 112 day-use caplets and 56 night-use caplets designed to provide comprehensive relief from cold and flu symptoms.
The daytime capsules are meant to reduce pain and fever, suppress cough, lubricate airways, and promote decongestion. In contrast, the evening capsules contain antihistamines for throat and nasal symptoms and to induce drowsiness.
For those concerned about whether their medicine is part of the recall, the identifying information includes the National Drug Code/NDC number 63981-795-81, Lot numbers P139953 or P139815, and an expiration date of August 2026.
It is worth noting that the specific quality control issues leading to the recall were not disclosed, raising questions about transparency in the regulatory process.
As the FDA considers banning phenylephrine, a long-standing ingredient in many cold and flu medicines, Americans may soon find their options for affordable, over-the-counter relief severely limited.
This overreach impacts consumer choice and raises concerns about the rising costs of healthcare and the erosion of personal freedom in making health decisions.
As winter approaches and cold and flu season sets in, this recall leaves many patriotic Americans questioning the motives behind such regulatory actions.
Copyright 2024, GoRealNewsNow.com
